Top-Rated Charity
View similar charities
Ratings & Metrics
Financial Documents
| Entity | Document Type | Tax ID |
|---|---|---|
| The Salk Institute for Biological Studies | Audited Financial Statements | 95-2160097 |
| The Salk Institute for Biological Studies | IRS Form 990 | 95-2160097 |
|
Entity: The Salk Institute for Biological Studies Document Type: Audited Financial Statements Tax ID: 95-2160097 |
|
Entity: The Salk Institute for Biological Studies Document Type: IRS Form 990 Tax ID: 95-2160097 |
Governance & Transparency
CharityWatch evaluates certain criteria related to a charity's Governance and Transparency. Donors may want to consider a charity's willingness to be open and transparent with CharityWatch to be a good litmus test for determining its commitment to public accountability.
Top Salaries
| Name | Title | Compensation | |
|---|---|---|---|
| 1 | William R. Brody, M.D. | Past President | $1,004,258 |
| 2 | Marsha A. Chandler | Executive VP/COO | $578,126 |
| 3 | Kim E. Witmer | Senior VP/CFO | $453,988 |
|
1 Name: William R. Brody, M.D. Title: Past President Compensation: $1,004,258 |
|
2 Name: Marsha A. Chandler Title: Executive VP/COO Compensation: $578,126 |
|
3 Name: Kim E. Witmer Title: Senior VP/CFO Compensation: $453,988 |
Analysts' Notes
CharityWatch Analysts perform an in-depth analysis of charities' audited financial statements and IRS tax filings, and often review other documents such as state filings, annual reports, and fundraising contracts during their evaluations. Below are select notes that CharityWatch believes may be of interest to donors.
| According to the Salk Institute for Biological Studies (the Institute) audit of June 30, 2016 (Note 11, Concentrations of Credit Risk): "The Institute receives funds under various research grants from federal and non-federal agencies. Funding from the National Institutes of Health represents approximately 51 percent and 53 percent of total grant revenue for the years ended June 30, 2016 and 2015, respectively." |
| According to The Salk Institute for Biological Studies (the Institute) audit of June 30, 2016 (Note 12, Related Party): "In May 2006, the Institute and three other research institutions formed the San Diego Consortium for Regenerative Medicine, subsequently renamed Sanford Consortium for Regenerative Medicine ('SCRM') and joined by a fifth research institution. SCRM was formed to coordinate the institutions' resources, personnel, and programs for scientific research and education in the field of stem cell research and related fields. The nine-member board of SCRM includes a member of the Institute's Board and the Institute's President/Chief Executive Officer." "In October 2009, the consortium members and SCRM executed an agreement (the 'Collaboratory Agreement') in which SCRM grants the members a non-exclusive license to use space for stem cell research in SCRM's research facility, which was ready for occupancy on January 1, 2012. The initial term of the Collaboratory Agreement is 10 years with options to extend. Under the agreement, the members agree to pay a license fee equal to each member's allocable share of licensed space debt service and operating expenses. The Institute's license fee and operating expenses for the use of three modules in SCRM's building are expected to be $191 and $238 per year [$s in thousands], respectively, with increases or decreases to the amounts each year based on actual expenses..." |
| According to The Salk Institute for Biological Studies audit of June 30, 2016 (Note 10): "Commitments -- At June 30, 2016, contractual commitments on construction and purchases pending or in process are $10,200 [$s in thousands]." |
| According to The Salk Institute for Biological Studies tax filing for the fiscal year ended June 30, 2016, the Institute reports for Loans to and/or from Interested Persons a "home loan" made by the Institute to two professors in the amounts of $168,000 and $100,000, with each loan having that same amount, respectively, for the balance due at June 30, 2016. It is also reported that the board or a committee approved the loans, there are written agreements for the loans, and the loans are not in default (IRS Form 990, Schedule L, Part II). |